Portfolio
Apr' 23 dividend portfolio update: expanding coverage
I review April's results from dividend shares in my model portfolio.
Roland Head
The Dividend Note
Dividend notes (28/04/23): peak profits? NWG, MGAM
I review the latest results from UK dividend shares NatWest and Morgan Advanced Materials.
The Dividend Note
Dividend notes (27/04/23): optimism vs uncertainty - TW, SBRY, BARC, SXS
I review the latest results and updates from UK dividend shares Taylor Wimpey, Sainsbury's, Barclays, and Spectris.
The Dividend Note
Dividend notes (26/04/23): the road to recovery? ABF, WTB, GSK, PSN
This update reviews recent results from UK dividend shares Associated British Foods, Whitbread, GSK and Persimmon.
Dividend share reviews
Is Morgan Sindall a top dividend share to buy now?
FTSE 250 construction group Morgan Sindall (LON:MGNS) offers a near-6% yield. Does this dividend share offer a cyclical buying opportunity?
Portfolio
Q1 2023: a big loss leaves me lagging the market
There was good and bad news for my quality dividend portfolio perform during the first quarter of 2023. In this review, I crunch the numbers.
Podcasts
Shares Podcast: ITV with Maynard Paton & Roland Head
I've recorded a podcast with Maynard Paton discussing ITV (LON:ITV) shares. The stock's 6% dividend yield is an obvious temptation, but we discuss broader reasons why the shares might be undervalued.
Portfolio
March '23 dividend portfolio update: better than expected
With one exception, results from my quality dividend stocks in March were generally better than I expected. Companies covered include #DLG.
Dividend share reviews
Should I sell my Direct Line Insurance shares?
Direct Line Insurance (LON:DLG) had a difficult time last year. Roland Head reviews the insurer's 2022 results and flags up his concerns.
Portfolio
Feb '23 dividend portfolio update: defensive quality
I review February's results from five shares in my quality dividend model portfolio.
Podcasts
Podcast: Telecom Plus (LON:TEP) with Maynard Paton & Roland Head
I've recorded a podcast with Maynard Paton discussing Telecom Plus (LON:TEP) shares. After a 25% share price drop, is it time to buy?
Dividend share reviews
Is new GSK a quality dividend share?
FTSE 100 pharma group GSK (LON:GSK) has streamlined its business and its financial health seems to be improving. Should I consider the shares for my dividend portfolio?